News crossing on the Phase 3 results from the trial of Novavax.
- efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom (UK)
UK PM Johnson moving the approval process forward in its wake.
UK PM Johnson moving the approval process forward in its wake.
Most Popular
Sponsored
CA gasoline prices surge 30 cents/gal as refineries close. Russian oil imports offer a lifeline, but at what cost?
BX invests $400M in TEVA's drug, betting on high returns. With a 11.5 P/E, TEVA's a value play for aggressive investors.
Mag 7 earnings mixed; S&P 500 futures dip. Oil jumps, Fed holds rates. Watch valuations!
Google's cloud sales beat $20B on AI, shares jump 6.6%. Meta's AI spend up, shares drop 6%.
France's Q1 GDP flatlines amid soaring energy costs; inflation hits 2.2%. Eurozone growth slows.
GTBIF eyes 100% gain on potential reclass, banking reform. High P/E ratio is a risk.
SpaceX IPO eyes $2T valuation, but faces historical IPO stumbles & high P/S risks.
Sponsored
Must Read